STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $289,000 | +20.9% | 26,000 | 0.0% | 0.35% | +27.0% |
| Q2 2017 | $239,000 | +7.7% | 26,000 | 0.0% | 0.28% | +14.4% |
| Q1 2017 | $222,000 | -20.1% | 26,000 | 0.0% | 0.24% | -18.2% |
| Q4 2016 | $278,000 | +4.1% | 26,000 | 0.0% | 0.30% | +17.4% |
| Q3 2016 | $267,000 | +50.0% | 26,000 | -1.2% | 0.25% | +51.5% |
| Q2 2016 | $178,000 | +63.3% | 26,305 | +12.9% | 0.17% | +67.0% |
| Q1 2016 | $109,000 | -6.0% | 23,305 | +27.3% | 0.10% | +9.9% |
| Q4 2015 | $116,000 | -41.4% | 18,305 | +9.0% | 0.09% | -32.6% |
| Q2 2015 | $198,000 | +7.0% | 16,796 | +31.3% | 0.14% | -2.2% |
| Q1 2015 | $185,000 | -26.6% | 12,796 | -13.5% | 0.14% | +1.5% |
| Q4 2014 | $252,000 | -9.0% | 14,796 | -33.3% | 0.14% | -8.7% |
| Q3 2014 | $277,000 | +30.0% | 22,196 | +53.1% | 0.15% | +40.6% |
| Q2 2014 | $213,000 | -10.1% | 14,500 | +19.8% | 0.11% | -17.8% |
| Q4 2013 | $237,000 | – | 12,100 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 579,800 | $7,224,000 | 1.01% |
| VHCP Management, LLC | 71,000 | $884,000 | 0.40% |
| Healthcare Value Capital, LLC | 16,464 | $205,000 | 0.20% |
| CARL DOMINO INC | 22,196 | $277,000 | 0.15% |
| TFS CAPITAL LLC | 120,112 | $1,497,000 | 0.13% |
| Private Capital Advisors, Inc. | 31,064 | $387,000 | 0.12% |
| Artal Group S.A. | 170,000 | $2,118,000 | 0.08% |
| TimesSquare Capital Management, LLC | 801,225 | $9,983,000 | 0.06% |
| Baker Brothers Advisors | 338,671 | $4,220,000 | 0.05% |
| STONERIDGE INVESTMENT PARTNERS LLC | 19,399 | $242,000 | 0.04% |